Prabhudas Lilladher is bullish on Krishna Institute of Medical Sciences has recommended buy rating on the stock with a target price of Rs 2000 in its research report dated November 08, 2023.

Buy Krishna Institute of Medical Sciences; target of Rs 2000: Prabhudas Lilladher

The report is based on the agency’s sample of nine listed hospital chains -- Apollo Hospitals, Aster DM Healthcare, Fortis Healthcare, Healthcare Global Enterprises, Krishna Institute of Medical Sciences, Max Healthcare, Narayana Hrudayalaya, Rainbow Children’s Medicare and Shalby Hospital.

Corporate hospitals to see 8-10 pc revenue growth in FY24: Report

Prabhudas Lilladher is bullish on Krishna Institute of Medical Sciences has recommended buy rating on the stock with a target price of Rs 2000 in its research report dated August 09, 2023.

The stock has given a short-term breakout.

Buy Krishna Institute of Medical Sciences., target price Rs 1950: Jayesh Bhanushali

Hyderabad-based Krishna Institute of Medical Sciences reported a 15.5 percent YoY rise in Q1 consolidated profit to Rs 80.8 crore driven by a healthy topline.

KIMS declines despite a profitable Q1

Krishna Institute of Medical Sciences (KIMS) plans to expand to 8,000 beds in 2-3 years in Telangana, AP, Maharashtra and Karnataka. Expansion includes new therapies, departments and units in Visakhapatnam, Secunderabad, Nagpur. Consolidation of Sunshine Hospitals yielded 19% revenue contribution.

KIMS to double number of beds to 8,000 in 2 years

Timken India, Aether Industries, Krishna Institute Of Medical Sciences Ltd (KIMS), CreditAccess Grameen, NMDC and Kalyan Jewellers were among midcaps that saw MF buying during the month.

IEX, Bandhan, ZEEL, Cyient, PB Fintech shares: Midcap stocks that MFs sold in June

Prabhudas Lilladher is bullish on Krishna Institute of Medical Sciences has recommended buy rating on the stock with a target price of Rs 1660 in its research report dated May 20, 2023.

Buy Krishna Institute of Medical Sciences; target of Rs 1660: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Krishna Institute of Medical Sciences has recommended buy rating on the stock with a target price of Rs 1660 in its research report dated March 20, 2023.

Abhinay Bollineni, KIMS Hospitals, Kaivaan Movdawalla, EY, Mitesh Daga, TPG Capital discuss the merger and acquisition (M&A) action in hospital space and scope for growth. Listen in.

#abhinaybollineni #kaivaanmovdawalla #miteshdaga #hospital #hospitals #deals #mergers #acquisition #growth #cnbctv18 #businessnews  #businessnewstoday #businessnewsinenglish #sharemarkettoday 

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. #n18oc_business  Catch all your favourite shows, exclusive videos, big-ticket interviews and more here. 

You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

n18oc_business

Hospital M&A Action | Decoding The Factors, Scope Of Growth & More | Big Deal | CNBC-TV18

Abhinay Bollineni, KIMS Hospitals, Kaivaan Movdawalla, EY, Mitesh Daga, TPG Capital decode the factors for hospital space to remain unfazed in deal actions. Listen in.

#abhinaybollineni #kaivaanmovdawalla #miteshdaga #hospital #hospitals #deals #mergers #acquisition #cnbctv18 #businessnews  #businessnewstoday #businessnewsinenglish #sharemarkettoday  #cnbctv18 

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. #n18oc_business  Catch all your favourite shows, exclusive videos, big-ticket interviews and more here. 

You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

n18oc_business

Analyzing Factors For Hospital Space To Remain Unfazed In M&A Action | Big Deal | CNBC-TV18

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Krishna Institute of Medical Sciences Ltd is engaged in the business of rendering medical and healthcare services. Its hospital network is spread across Andhra Pradesh,Telangana, Karnataka, Odisha, Tamil Nadu and Central India.